HEADER VIRAL PROTEIN, HYDROLASE 31-MAY-22 8D35 TITLE CRYSTAL STRUCTURE OF SARS-COV-2 MAIN PROTEASE (MPRO) C145A MUTANT IN TITLE 2 COMPLEX WITH PEPTIDE FROM HUMAN TRNA METHYLTRANSFERASE TRMT1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE NSP5; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 3264-3569; COMPND 5 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5, COMPND 6 NSP5,SARS CORONAVIRUS MAIN PROTEINASE; COMPND 7 EC: 3.4.22.69; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: TRNA (GUANINE(26)-N(2))-DIMETHYLTRANSFERASE; COMPND 12 CHAIN: C; COMPND 13 FRAGMENT: UNP RESIDUES 526-536; COMPND 14 SYNONYM: TRNA 2,2-DIMETHYLGUANOSINE-26 METHYLTRANSFERASE, COMPND 15 TRNA(GUANINE-26,N(2)-N(2)) METHYLTRANSFERASE,TRNA(M(2,2)G26) COMPND 16 DIMETHYLTRANSFERASE; COMPND 17 EC: 2.1.1.216; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 GENE: REP, 1A-1B; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VARIANT: ROSETTA; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606 KEYWDS PROTEASE, HOST-VIRUS PROTEIN INTERACTION, RNA MODIFYING ENZYME, VIRAL KEYWDS 2 PROTEIN, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.D'OLIVIERA,J.S.MUGRIDGE REVDAT 5 22-NOV-23 8D35 1 TITLE JRNL REVDAT 4 25-OCT-23 8D35 1 REMARK REVDAT 3 15-MAR-23 8D35 1 JRNL REVDAT 2 08-MAR-23 8D35 1 JRNL REVDAT 1 01-MAR-23 8D35 0 JRNL AUTH A.D'OLIVIERA,X.DAI,S.MOTTAGHINIA,E.P.GEISSLER,L.ETIENNE, JRNL AUTH 2 Y.ZHANG,J.S.MUGRIDGE JRNL TITL RECOGNITION AND CLEAVAGE OF HUMAN TRNA METHYLTRANSFERASE JRNL TITL 2 TRMT1 BY THE SARS-COV-2 MAIN PROTEASE. JRNL REF ELIFE 2023 JRNL REFN ESSN 2050-084X JRNL DOI 10.7554/ELIFE.91168.1 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.DA OLIVIERA,X.DAI,S.MOTTAGHINIA,E.P.GEISSLER,L.ETIENNE, REMARK 1 AUTH 2 Y.ZHANG,J.S.MUGRIDGE REMARK 1 TITL RECOGNITION AND CLEAVAGE OF HUMAN TRNA METHYLTRANSFERASE REMARK 1 TITL 2 TRMT1 BY THE SARS-COV-2 MAIN PROTEASE. REMARK 1 REF BIORXIV 2023 REMARK 1 REFN ISSN 2692-8205 REMARK 1 PMID 36865253 REMARK 1 DOI 10.1101/2023.02.20.529306 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 55640 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.580 REMARK 3 FREE R VALUE TEST SET COUNT : 1994 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.3400 - 4.5700 1.00 4110 155 0.1782 0.1950 REMARK 3 2 4.5700 - 3.6300 1.00 3947 142 0.1534 0.1785 REMARK 3 3 3.6300 - 3.1700 1.00 3899 145 0.1736 0.2226 REMARK 3 4 3.1700 - 2.8800 1.00 3875 142 0.1878 0.2149 REMARK 3 5 2.8800 - 2.6700 0.99 3850 148 0.1867 0.2666 REMARK 3 6 2.6700 - 2.5200 1.00 3812 142 0.1976 0.2365 REMARK 3 7 2.5200 - 2.3900 0.99 3853 144 0.2047 0.2621 REMARK 3 8 2.3900 - 2.2900 0.99 3795 137 0.2071 0.2617 REMARK 3 9 2.2900 - 2.2000 0.99 3806 154 0.2148 0.2289 REMARK 3 10 2.2000 - 2.1200 0.99 3785 131 0.2134 0.2454 REMARK 3 11 2.1200 - 2.0600 0.99 3782 144 0.2288 0.2834 REMARK 3 12 2.0600 - 2.0000 0.99 3776 141 0.2314 0.2717 REMARK 3 13 2.0000 - 1.9400 0.98 3777 137 0.2504 0.2861 REMARK 3 14 1.9400 - 1.9000 0.93 3579 132 0.2696 0.2789 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.204 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.301 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.97 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4838 REMARK 3 ANGLE : 0.841 6569 REMARK 3 CHIRALITY : 0.053 741 REMARK 3 PLANARITY : 0.006 852 REMARK 3 DIHEDRAL : 21.262 656 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8D35 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1000265949. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAR-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 17-ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.920219 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS JAN 31, 2020 REMARK 200 DATA SCALING SOFTWARE : XDS JAN 10, 2022 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55694 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 29.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 13.80 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 14.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.470 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: PDB ENTRY 7MGS REMARK 200 REMARK 200 REMARK: RHOMBOHEDRAL SHAPED PLATES REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-21.5% PEG3350, 100 MM SODIUM REMARK 280 CHLORIDE, DIFFRACTION-QUALITY CRYSTALS OBTAINED FROM SEEDING, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.89350 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.62600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.01450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.62600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.89350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 50.01450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 SER A 301 REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 465 GLY B -1 REMARK 465 PHE B 140 REMARK 465 LEU B 141 REMARK 465 ASN B 142 REMARK 465 GLY B 143 REMARK 465 GLN B 306 REMARK 465 ILE C 535 REMARK 465 ARG C 536 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -128.87 54.79 REMARK 500 ASN A 84 -121.36 53.68 REMARK 500 TYR A 154 -130.58 69.19 REMARK 500 ASP B 33 -130.46 54.25 REMARK 500 ASN B 51 73.88 -154.01 REMARK 500 ASN B 84 -127.13 54.35 REMARK 500 TYR B 154 -90.77 57.47 REMARK 500 HIS B 164 -52.01 -121.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 402 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 22 O REMARK 620 2 VAL A 42 O 78.7 REMARK 620 3 CYS A 44 O 134.1 81.4 REMARK 620 4 HOH A 624 O 79.7 138.7 89.0 REMARK 620 5 HOH A 689 O 104.6 131.0 119.6 88.5 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 401 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN B 221 O REMARK 620 2 ASN B 221 OD1 75.7 REMARK 620 3 PHE B 223 O 110.3 96.4 REMARK 620 4 ASP B 263 O 151.6 121.7 90.9 REMARK 620 5 ASP B 263 OD1 94.2 169.8 85.7 68.1 REMARK 620 6 HOH B 549 O 79.2 98.2 164.2 76.3 81.0 REMARK 620 N 1 2 3 4 5 DBREF 8D35 A 1 306 UNP P0DTD1 R1AB_SARS2 3264 3569 DBREF 8D35 B 1 306 UNP P0DTD1 R1AB_SARS2 3264 3569 DBREF 8D35 C 526 536 UNP Q9NXH9 TRM1_HUMAN 526 536 SEQADV 8D35 GLY A -1 UNP P0DTD1 EXPRESSION TAG SEQADV 8D35 SER A 0 UNP P0DTD1 EXPRESSION TAG SEQADV 8D35 ALA A 145 UNP P0DTD1 CYS 3408 ENGINEERED MUTATION SEQADV 8D35 GLY B -1 UNP P0DTD1 EXPRESSION TAG SEQADV 8D35 SER B 0 UNP P0DTD1 EXPRESSION TAG SEQADV 8D35 ALA B 145 UNP P0DTD1 CYS 3408 ENGINEERED MUTATION SEQRES 1 A 308 GLY SER SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY SEQRES 2 A 308 LYS VAL GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR SEQRES 3 A 308 THR THR LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR SEQRES 4 A 308 CYS PRO ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU SEQRES 5 A 308 ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN SEQRES 6 A 308 HIS ASN PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG SEQRES 7 A 308 VAL ILE GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU SEQRES 8 A 308 LYS VAL ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS SEQRES 9 A 308 PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU SEQRES 10 A 308 ALA CYS TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS SEQRES 11 A 308 ALA MET ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU SEQRES 12 A 308 ASN GLY SER ALA GLY SER VAL GLY PHE ASN ILE ASP TYR SEQRES 13 A 308 ASP CYS VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU SEQRES 14 A 308 PRO THR GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN SEQRES 15 A 308 PHE TYR GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA SEQRES 16 A 308 ALA GLY THR ASP THR THR ILE THR VAL ASN VAL LEU ALA SEQRES 17 A 308 TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE SEQRES 18 A 308 LEU ASN ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU SEQRES 19 A 308 VAL ALA MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP SEQRES 20 A 308 HIS VAL ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY SEQRES 21 A 308 ILE ALA VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU SEQRES 22 A 308 LEU GLN ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER SEQRES 23 A 308 ALA LEU LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL SEQRES 24 A 308 ARG GLN CYS SER GLY VAL THR PHE GLN SEQRES 1 B 308 GLY SER SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY SEQRES 2 B 308 LYS VAL GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR SEQRES 3 B 308 THR THR LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR SEQRES 4 B 308 CYS PRO ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU SEQRES 5 B 308 ASN PRO ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN SEQRES 6 B 308 HIS ASN PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG SEQRES 7 B 308 VAL ILE GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU SEQRES 8 B 308 LYS VAL ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS SEQRES 9 B 308 PHE VAL ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU SEQRES 10 B 308 ALA CYS TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS SEQRES 11 B 308 ALA MET ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU SEQRES 12 B 308 ASN GLY SER ALA GLY SER VAL GLY PHE ASN ILE ASP TYR SEQRES 13 B 308 ASP CYS VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU SEQRES 14 B 308 PRO THR GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN SEQRES 15 B 308 PHE TYR GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA SEQRES 16 B 308 ALA GLY THR ASP THR THR ILE THR VAL ASN VAL LEU ALA SEQRES 17 B 308 TRP LEU TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE SEQRES 18 B 308 LEU ASN ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU SEQRES 19 B 308 VAL ALA MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP SEQRES 20 B 308 HIS VAL ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY SEQRES 21 B 308 ILE ALA VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU SEQRES 22 B 308 LEU GLN ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER SEQRES 23 B 308 ALA LEU LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL SEQRES 24 B 308 ARG GLN CYS SER GLY VAL THR PHE GLN SEQRES 1 C 11 GLU PRO ARG LEU GLN ALA ASN PHE THR ILE ARG HET CL A 401 1 HET NA A 402 1 HET GOL A 403 6 HET NA B 401 1 HET GOL B 402 6 HET GOL B 403 6 HETNAM CL CHLORIDE ION HETNAM NA SODIUM ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 CL CL 1- FORMUL 5 NA 2(NA 1+) FORMUL 6 GOL 3(C3 H8 O3) FORMUL 10 HOH *359(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 ASN A 53 ARG A 60 1 8 HELIX 4 AA4 SER A 62 HIS A 64 5 3 HELIX 5 AA5 ILE A 200 ASN A 214 1 15 HELIX 6 AA6 THR A 226 MET A 235 1 10 HELIX 7 AA7 LYS A 236 ASN A 238 5 3 HELIX 8 AA8 THR A 243 GLY A 258 1 16 HELIX 9 AA9 ALA A 260 GLY A 275 1 16 HELIX 10 AB1 THR A 292 CYS A 300 1 9 HELIX 11 AB2 SER B 10 GLY B 15 1 6 HELIX 12 AB3 HIS B 41 CYS B 44 5 4 HELIX 13 AB4 GLU B 47 ASN B 51 5 5 HELIX 14 AB5 ASN B 53 ARG B 60 1 8 HELIX 15 AB6 SER B 62 PHE B 66 5 5 HELIX 16 AB7 ILE B 200 ASN B 214 1 15 HELIX 17 AB8 THR B 226 TYR B 237 1 12 HELIX 18 AB9 THR B 243 LEU B 250 1 8 HELIX 19 AC1 LEU B 250 THR B 257 1 8 HELIX 20 AC2 ALA B 260 GLY B 275 1 16 HELIX 21 AC3 THR B 292 GLY B 302 1 11 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 PHE A 66 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 89 N VAL A 36 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N SER A 81 O LYS A 88 SHEET 1 AA2 5 VAL A 73 LEU A 75 0 SHEET 2 AA2 5 PHE A 66 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 AA2 5 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA2 5 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA2 5 ASN C 532 PHE C 533 -1 O ASN C 532 N THR A 26 SHEET 1 AA3 3 TYR A 101 PHE A 103 0 SHEET 2 AA3 3 VAL A 157 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O THR A 175 N MET A 162 SHEET 1 AA4 5 SER A 121 ALA A 129 0 SHEET 2 AA4 5 THR A 111 TYR A 118 -1 N ALA A 116 O SER A 123 SHEET 3 AA4 5 VAL A 148 ASN A 151 -1 O PHE A 150 N SER A 113 SHEET 4 AA4 5 VAL A 157 GLU A 166 -1 O SER A 158 N ASN A 151 SHEET 5 AA4 5 ARG C 528 LEU C 529 -1 O ARG C 528 N GLU A 166 SHEET 1 AA5 7 VAL B 73 LEU B 75 0 SHEET 2 AA5 7 LEU B 67 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 AA5 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA5 7 THR B 25 LEU B 32 -1 O GLY B 29 N VAL B 18 SHEET 5 AA5 7 VAL B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA5 7 VAL B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 AA5 7 VAL B 77 GLN B 83 -1 N SER B 81 O LYS B 88 SHEET 1 AA6 5 LYS B 100 PHE B 103 0 SHEET 2 AA6 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA6 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA6 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA6 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 AA7 3 LYS B 100 PHE B 103 0 SHEET 2 AA7 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA7 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 LINK O CYS A 22 NA NA A 402 1555 1555 2.72 LINK O VAL A 42 NA NA A 402 1555 1555 3.18 LINK O CYS A 44 NA NA A 402 1555 1555 3.00 LINK NA NA A 402 O HOH A 624 1555 1555 2.57 LINK NA NA A 402 O HOH A 689 1555 1555 2.64 LINK O ASN B 221 NA NA B 401 1555 1555 2.71 LINK OD1 ASN B 221 NA NA B 401 1555 1555 2.25 LINK O PHE B 223 NA NA B 401 1555 1555 2.30 LINK O ASP B 263 NA NA B 401 1555 1555 2.98 LINK OD1 ASP B 263 NA NA B 401 1555 1555 2.29 LINK NA NA B 401 O HOH B 549 1555 1555 2.27 CRYST1 67.787 100.029 103.252 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014752 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009997 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009685 0.00000